Literature DB >> 4870882

Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids.

P P Carbone, C Spurr, M Schneiderman, J Scotto, J F Holland, B Shnider.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4870882

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

1.  Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.

Authors:  G P Canellos; V T DeVita; R C Young; B A Chabner; P S Schein; R E Johnson
Journal:  Br J Cancer Suppl       Date:  1975-03

2.  Defining principles of combination drug mechanisms of action.

Authors:  Justin R Pritchard; Peter M Bruno; Luke A Gilbert; Kelsey L Capron; Douglas A Lauffenburger; Michael T Hemann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-18       Impact factor: 11.205

3.  Clinical screening of epipodophyllotoxin VM26 in malignant lymphomas and solid tumours.

Authors: 
Journal:  Br Med J       Date:  1972-06-24

Review 4.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  [Clinical manifestation and chemotherapy in Hodgkin's disease].

Authors:  C G Schmidt
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

6.  MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma.

Authors:  W Oster; T Forsthuber; H H Hennekeuser; H Gamm; A Lindemann; G Schmitz; H G Fuhr; R Hinterberger; H Kreiter; W Thoenes
Journal:  Blut       Date:  1990-01

Review 7.  Why does cytotoxic chemotherapy cure only some cancers?

Authors:  Philip Savage; Justin Stebbing; Mark Bower; Tim Crook
Journal:  Nat Clin Pract Oncol       Date:  2008-11-04

8.  Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.

Authors:  G Bonadonna; M De Lena; A Lattuada; F Milani; S Monfardini; G Beretta
Journal:  Br J Cancer Suppl       Date:  1975-03

Review 9.  Promising personalized therapeutic options for diffuse large B-cell Lymphoma Subtypes with oncogene addictions.

Authors:  James J Steinhardt; Ronald B Gartenhaus
Journal:  Clin Cancer Res       Date:  2012-06-27       Impact factor: 12.531

Review 10.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.